aspirinhypertensionTimedup andgo test3%40y.o.40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor40-70 y.o.,ASCVD ≥10%, lowbleeding risk52y.o.q2ydiabetes40-59 y.o.,ASCVD ≥10%, lowbleeding riskbreastcancerFractureRiskAssessmentToolaromataseinhibitors< 60y.o.Tyrer-Cuzickmodel≤q2ycervicalcancermultidoseinitial series,then 1 doseat 2-6months≥ 200mg/dLdyslipidemiaHepatitisBq1ylungcancerhormonetherapypneumococcalwomenage 55-64 y.o.q15yoverweight/ obesityinsufficientevidenceforscreeningq3y60y.o.cardiovasculardisease≥6.5%statinherpeszoster≥ 100mg/dLcommunity-dwelling,postmenopausalwomen40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsHepatitisCdepression40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factordementia50y.o.PREVENTequationovariancancerq5yanxietyq1-2ymammogrambased on lifeexpectancy /health status75y.o.raloxifene2 doses,2-6monthsaparttamoxifenGailmodel≥20%≥ 140mg/dLq1ymammogramtobaccouse1 dose; 2doses (2-6monthsapart) ifimmunocompcolorectalcancer≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsHIV65y.o.≥ 126mg/dL≥5.7%aspirinhypertensionTimedup andgo test3%40y.o.40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor40-70 y.o.,ASCVD ≥10%, lowbleeding risk52y.o.q2ydiabetes40-59 y.o.,ASCVD ≥10%, lowbleeding riskbreastcancerFractureRiskAssessmentToolaromataseinhibitors< 60y.o.Tyrer-Cuzickmodel≤q2ycervicalcancermultidoseinitial series,then 1 doseat 2-6months≥ 200mg/dLdyslipidemiaHepatitisBq1ylungcancerhormonetherapypneumococcalwomenage 55-64 y.o.q15yoverweight/ obesityinsufficientevidenceforscreeningq3y60y.o.cardiovasculardisease≥6.5%statinherpeszoster≥ 100mg/dLcommunity-dwelling,postmenopausalwomen40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsHepatitisCdepression40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factordementia50y.o.PREVENTequationovariancancerq5yanxietyq1-2ymammogrambased on lifeexpectancy /health status75y.o.raloxifene2 doses,2-6monthsaparttamoxifenGailmodel≥20%≥ 140mg/dLq1ymammogramtobaccouse1 dose; 2doses (2-6monthsapart) ifimmunocompcolorectalcancer≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsHIV65y.o.≥ 126mg/dL≥5.7%

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. aspirin
  2. hypertension
  3. Timed up and go test
  4. 3%
  5. 40 y.o.
  6. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  7. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  8. 52 y.o.
  9. q2y
  10. diabetes
  11. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  12. breast cancer
  13. Fracture Risk Assessment Tool
  14. aromatase inhibitors
  15. < 60 y.o.
  16. Tyrer-Cuzick model
  17. ≤ q2y
  18. cervical cancer
  19. multidose initial series, then 1 dose at 2-6 months
  20. ≥ 200 mg/dL
  21. dyslipidemia
  22. Hepatitis B
  23. q1y
  24. lung cancer
  25. hormone therapy
  26. pneumococcal
  27. women age 55-64 y.o.
  28. q15y
  29. overweight / obesity
  30. insufficient evidence for screening
  31. q3y
  32. 60 y.o.
  33. cardiovascular disease
  34. ≥ 6.5%
  35. statin
  36. herpes zoster
  37. ≥ 100 mg/dL
  38. community-dwelling, postmenopausal women
  39. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  40. Hepatitis C
  41. depression
  42. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  43. dementia
  44. 50 y.o.
  45. PREVENT equation
  46. ovarian cancer
  47. q5y
  48. anxiety
  49. q1-2y mammogram based on life expectancy / health status
  50. 75 y.o.
  51. raloxifene
  52. 2 doses, 2-6 months apart
  53. tamoxifen
  54. Gail model
  55. ≥ 20%
  56. ≥ 140 mg/dL
  57. q1y mammogram
  58. tobacco use
  59. 1 dose; 2 doses (2-6 months apart) if immunocomp
  60. colorectal cancer
  61. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  62. HIV
  63. 65 y.o.
  64. ≥ 126 mg/dL
  65. ≥ 5.7%